Sibutramine
Back to searchMolecule Structure
Scientific Name
Sibutramine
Description of the Drug
Sibutramine is a norepinephrine, serotonin and dopamine reuptake inhibitor indicated to assist with weight loss in obesity.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01105
http://www.drugbank.ca/drugs/DB01105
Brand Name(s)
Reductil
Company Owner(s)
Abbott Laboratories Pharmaceutical Products Div
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Monoamine transporter | PROTEIN FAMILY | INHIBITOR | CHEMBL2363064 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2955 | ||
PharmGKB | PA451344 | ||
Human Metabolome Database | HMDB0015237 | ||
DrugBank | DB01105 | ||
PubChem: Thomson Pharma | 14750864 | ||
PubChem | 5210 | ||
Mcule | MCULE-6656338642 | ||
LINCS | LSM-5000 | ||
Nikkaji | J247.963J | ||
BindingDB | 84742 | ||
EPA CompTox Dashboard | DTXSID1023578 | ||
DrugCentral | 2440 | ||
ChemicalBook | CB5708493 | CB3783665 | |
Guide to Pharmacology | 2586 | ||
rxnorm | SIBUTRAMINE | SIBUTRAMINE HYDROCHLORIDE | SIBUTRAMINE HYDROCHLORIDE MONOHYDRATE |
KEGG Ligand | C07247 | ||
ChEBI | 9137 |